Related Experiment Videos
A method for quantitating motor deficits in a nonhuman primate following MPTP-induced hemiparkinsonism and
Abstract:
This report describes a nonhuman primate model of MPTP-induced hemiparkinsonism and the recovery of motor function following co-grafting of adrenal medullary tissue and peripheral nerve into the lesioned area of the brain. A rhesus monkey (Macaca mulatta) trained to perform a complex, discrete-trial, operant task served as the subject. After behavioral performance on the task had stabilized and a high level of accuracy was maintained, 0.4 mg/kg MPTP was infused acutely via the left carotid artery to produce a marked impairment of movement of the right arm. Eighteen weeks later, medullary tissue from the left adrenal gland was grafted along with peripheral nerve into the left caudate nucleus. During the original baseline training condition, right- and left-hand performances were comparable on all dependent measures. However, right-hand performance was severely impaired following unilateral MPTP treatment, and left-hand performance was unaffected. Right-hand performance recovered only after adrenal medullary tissue was transplanted with peripheral nerve into the brain. Neuroanatomical analysis of brain tissue showed the anticipated neuronal loss in the left substantia nigra due to MPTP administration and evidence of adrenal medullary cell survival in the area of the co-graft. The data demonstrate that the rhesus monkey and the behavioral task developed during this study can be efficacious in characterizing the effects of MPTP on psychomotor function and in assessing the outcome of new strategies for treating Parkinson's disease.
Insights
This study developed a nonhuman primate model for Parkinson's disease. Co-grafting adrenal medullary tissue and peripheral nerve successfully restored motor function in MPTP-lesioned rhesus monkeys.
Area of Science:
- Neuroscience
- Primate Models
- Parkinson's Disease Research
Background:
- MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a neurotoxin that selectively destroys dopaminergic neurons, causing parkinsonism.
- Nonhuman primate models are crucial for studying Parkinson's disease (PD) pathogenesis and testing therapeutic strategies.
Purpose of the Study:
- To establish a nonhuman primate model of hemiparkinsonism using MPTP.
- To evaluate the efficacy of co-grafting adrenal medullary tissue and peripheral nerve for motor function recovery in PD models.
Main Methods:
- A rhesus monkey was trained on a complex operant task.
- Unilateral MPTP infusion induced hemiparkinsonism, impairing motor function in one limb.
- Adrenal medullary tissue and peripheral nerve were co-grafted into the lesioned striatum.
Main Results:
- MPTP treatment caused severe motor deficits in the contralateral limb.
- Co-grafting of adrenal medullary tissue and peripheral nerve led to significant recovery of motor function.
- Neuroanatomical analysis confirmed neuronal loss in the substantia nigra and survival of grafted cells.
Conclusions:
- The MPTP-treated rhesus monkey serves as an effective model for PD research.
- Co-grafting adrenal medullary tissue with peripheral nerve shows promise as a therapeutic strategy for Parkinson's disease.
- This model is valuable for assessing novel treatments for Parkinson's disease.